EUROPEAN JOURNAL OF
PHARMACEUTICAL AND MEDICAL RESEARCH

An International Peer Reviewed Journal for Pharmaceutical, Medical & Biological Sciences

An Official Publication of Society for Advance Healthcare Research (Reg. No. : 01/01/01/31674/16)

European Journal of Pharmaceutical and Medical Research (EJPMR) has indexed with various reputed international bodies like : Google Scholar , Indian Science Publications , InfoBase Index (In Process) , SOCOLAR, China , Research Bible, Fuchu, Tokyo. JAPAN , International Society for Research activity (ISRA) , Scientific Indexing Services (SIS) , Polish Scholarly Bibliography , Global Impact Factor (GIF) (Under Process) , Universal Impact Factor , International Scientific Indexing (ISI), UAE  , Index Copernicus , CAS (A Division of American Chemical Society) USA (Under Process) , Directory of Open Access Journal (DOAJ, Sweden, in process) , UDLedge Science Citation Index , CiteFactor , Directory Of Research Journal Indexing (DRJI) , Indian citation Index (ICI) , Journal Index (JI, Under Process) , Directory of abstract indexing for Journals (DAIJ) , Open Access Journals (Under Process) , Impact Factor Services For International Journals (IFSIJ) , Cosmos Impact Factor , Jour Informatics (Under Process) , Eurasian Scientific Journal Index (ESJI) , International Innovative Journal Impact Factor (IIJIF) , Science Library Index, Dubai, United Arab Emirates , Pubmed Database [NLM ID: 101669306] (Under Process) , IP Indexing (IP Value 2.40) , Web of Science Group (Under Process) , Directory of Research Journals Indexing , 

 ISSN 2394-3211

Impact Factor: 6.222

 ICV - 79.57

Abstract

PETADOLEX®, A HERBAL EXTRACT FOR MIGRAINE PROPHYLAXIS WITH SPONTANEOUS CASE REPORTS OF DISPUTED LIVER INJURY: ROBUST CAUSALITY EVALUATION BY RUCAM, THE ROUSSEL UCLAF CAUSALITY ASSESSMENT METHOD

Rolf Teschke*, Axel Eickhoff, Johannes Schulze, Albrecht Wolff, Christian Frenzel and Dieter Melchart

ABSTRACT

Migraine is a major global health and economic burden, calling for efficient prophylactic medicines in patients with frequent attacks. Several synthetic drugs are in use but their low prophylactic efficacy of 20% to 40% is disappointing. Instead, the proprietary herbal medicine Petadolex® (PE), an analytically and pharmacologically well-defined, processed extract from Petasites hybridus (PH), reduces the frequency of migraine attacks by 48% to 60%, but claims of adverse liver reactions emerged that discourage its broader use. We analyzed 10 spontaneous case reports of suspected liver injury in assumed connection with the use of PE that were presented by hospital physicians to the manufacturer, who provided all case details upon our request. Using the robust, quantitative, structured and liver specific causality assessment method of RUCAM (Roussel Uclaf Causality Assessment Method), causality attribution was performed for PE. In none of the 10 liver cases, causality gradings of probable or highly probable were obtained for PE, indicating that these liver diseases cannot be attributed to PE with a high degree of probability; in detail, causality for PE was excluded in 3 patients, graded as unlikely in 5 patients, and possible in 2 patients without clinical relevance. In most of the 10 patient reports, alternative diagnoses, abundant comedications, and incomplete case data were major confounding variables, which complicated causality assessment. In conclusion, this clinical analysis and robust causality assessment by RUCAM failed to substantiate any potential liver injury by Petadolex® in the 10 spontaneous reports, opposing views to the contrary.

Keywords: Migraine; migraine treatment; Petasites hybridus; Petadolex; Pyrrolizidine alkaloids; suspected herbal hepatotoxicity; herb induced liver injury.


[Full Text Article]

INDEXING

NEWS & UPDATION

  • New Issue Published

    Its Our pleasure to inform you that, EJPMR 1 August 2020 Issue has been Published, Kindly check it on http://www.ejpmr.com/home/current_issues

  • EJPMR AUGUST ISSUE PUBLISHED

    AUGUST 2020 Issue has been successfully launched on 1 August 2020.

  • EJPMR New Impact Factor

    Its our Pleasure to Inform you that EJPMR Impact Factor has been increased from  5.804 to 6.222, due to high quality Publication at International Level

  • Index Copernicus Value

    EJPMR Received Index Copernicus Value 79.57, due to High Quality Publication in EJPMR at International Level

  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.

    .

  • Article Invited for Publication

    Article are invited for publication in EJPMR Coming Issue

Google Scholar Indian Science Publications InfoBase Index (In Process) SOCOLAR, China Research Bible, Fuchu, Tokyo. JAPAN International Society for Research activity (ISRA) Scientific Indexing Services (SIS) Polish Scholarly Bibliography Global Impact Factor (GIF) (Under Process) Universal Impact Factor International Scientific Indexing (ISI), UAE Index Copernicus CAS (A Division of American Chemical Society) USA (Under Process) Directory of Open Access Journal (DOAJ, Sweden, in process) UDLedge Science Citation Index CiteFactor Directory Of Research Journal Indexing (DRJI) Indian citation Index (ICI) Journal Index (JI, Under Process) Directory of abstract indexing for Journals (DAIJ) Open Access Journals (Under Process) Impact Factor Services For International Journals (IFSIJ) Cosmos Impact Factor Jour Informatics (Under Process) Eurasian Scientific Journal Index (ESJI) International Innovative Journal Impact Factor (IIJIF) Science Library Index, Dubai, United Arab Emirates Pubmed Database [NLM ID: 101669306] (Under Process) IP Indexing (IP Value 2.40) Web of Science Group (Under Process) Directory of Research Journals Indexing